XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Goodwill and Other Intangible Assets Goodwill (Tables)
 9 Months Ended
Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets and Goodwill [Table Text Block]
The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated write-offs of goodwill are as follows:
As of September 30, 2021As of December 31, 2020
(in millions)Gross Carrying Amount
Accumulated Amortization/ Write-offs(1)
Gross Carrying AmountAccumulated Amortization/ Write-offs
Technology-related$11,787 $(6,590)$11,059 $(6,179)
Patents497 (399)511 (407)
Other intangible assets1,859 (1,301)1,775 (1,220)
Amortizable intangible assets$14,143 $(8,290)$13,345 $(7,806)
    
Goodwill$21,720 $(9,900)$19,924 $(9,973)
IPR&D$254 $257 
Technology-related120 120 
Indefinite-lived intangible assets$374 $377 
(1)    In the fourth quarter of 2020, we recorded goodwill impairment charges of $73 million related to the Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. The goodwill impairment charges of $73 million related to the Specialty Pharmaceuticals business are no longer presented within accumulated write-offs above as of September 30, 2021.
Schedule of Goodwill [Table Text Block]
The following represents our goodwill balance by global reportable segment:
(in millions)MedSurgRhythm and NeuroCardiovascularTotal
As of December 31, 2020$2,059 $2,194 $5,697 $9,951 
Impact of foreign currency fluctuations and other changes in carrying amount(4)(1)(15)(20)
Goodwill acquired578 1,312 — 1,890 
As of September 30, 2021$2,633 $3,506 $5,682 $11,820